Nazarii Saiuk

Nazarii Saiuk

Auto-generated profile, based on publicly available information

Nazarii Saiuk

Ludwik Rydygier Specialist Hospital in Kraków, Złotej Jesieni 1 Estate, 31-826 Kraków, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
AMAleksandra Mazurkiewicz
Aleksandra Mazurkiewicz
WMWojciech Madry
Wojciech Madry
MKMagdalena Kołodziej
Magdalena Kołodziej
JMJoanna Męczyńska
Joanna Męczyńska
NSNazarii Saiuk
Nazarii Saiuk
WSWeronika Salasa
Weronika Salasa
Introduction Ashwagandha, a traditional Indian plant, is gaining increasive attention from scientists worldwide due to its potential health benefits, especially in the context of its antibacterial and anticancer properties. Aim of the study The aim of this review was to discuss recent findings regarding the impact of Withania Somnifera on antibacterial effect and its potential applications in anticancer therapy. Materials and methods: The paper was created based on the Pubmed and Google Scholar database. The literature was reviewed using the keywards: ,,Ashwagandha”, ,,Withania Somnifera”, ,,antibacterial ”, ,,anticancer”, ,,side effects”, ,,breats cancer”. Results Studies have confirmed Withania Somnifera, exhibits significant anticacterial and anticancer effects. It inhibits the growth of both Gram-negative and Gram-positive bacteria. Futhermore, it demonstrates anticancer activity, especially in breast cancer, by stimulating apoptosis, induction of cytotoxic effects on cancerous cells and increasing cell sensitivity to radiation. Conclusion Despite promising results, futher research on the benefits of Ashwagandha, particulary in the long term, is essential. There is growing need of more research of the potencial benefits of Ashwagandha in the treatment of various disorders including cancer and bacterial infections and to develop more effective therapeutic strategies. The need for large randomized studies comparing long term clinical effectiveness is emphasized

10 May 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
WSWeronika Salasa
Weronika Salasa
TSTomasz Seredyński
Tomasz Seredyński
WMWojciech Madry
Wojciech Madry
AMAleksandra Mazurkiewicz
Aleksandra Mazurkiewicz
MKMagdalena Kołodziej
Magdalena Kołodziej
JMJustyna Marcicka
Justyna Marcicka
Introduction In recent years, there has been tremendous development in medicine, including diabetology. A significant portion of these achievements pertains to pharmacological treatment. However, one should not overlook the advancement of devices necessary for monitoring glucose levels, such as glucometers or CGM and FGM systems. In this paper, I want to focus on how the use of glucose monitoring systems affects the course of diabetes. Aim of the study The aim of this study was to determine the impact of glucose monitoring systems (CGM and FGM) on parameters of metabolic control in diabetes. Materials and methods The article was created based on the PubMed and Scholar databases. The literature was analyzed using the following keywords: Continuous glucose monitor, CGM, flash glucose monitoring, FGM, type 1 diabetes, type 2 diabetes, diabetes mellitus, Metrics of Glycemic. Results Research has confirmed that the use of continuous glucose monitoring systems lowers HbA1c in patients with both type 1 and type 2 diabetes regardless of age and treatment modality. Furthermore, the use of CGM and FGM reduces the number of hypoglycemic episodes and increases time in range (TIR). Conclusions Thanks to the results obtained from numerous studies, it can be assumed that the use of continuous glucose monitoring systems is not only an adjunct to diabetes therapy but also an important component of it. With this technology combined with modern medications, we can achieve better glycemic control and, consequently, improve the quality of life of patients with diabetes.

8 July 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JMJoanna Męczyńska
Joanna Męczyńska
AMAleksandra Mazurkiewicz
Aleksandra Mazurkiewicz
WMWojciech Madry
Wojciech Madry
JMJustyna Marcicka
Justyna Marcicka
MKMagdalena Kołodziej
Magdalena Kołodziej
WSWeronika Salasa
Weronika Salasa
Introduction The urachal anomaly is a developmental defect, a remnant of fetal life consisting of a patent connection between the dome of the urinary bladder and the umbilicus. It can take various forms. Most commonly it occurs in males, very rarely in adults. The main symptoms associated with this condition are: foul-smelling discharge from the umbilicus, abdominal pain, hematuria, or recurrent urinary tract infections. Imaging plays a crucial role in the diagnosis of the persistent urachus. Aim of the studyThe aim of the study is to sentize doctors’ attention that patent urachus is the rare but possible diagnosis of acute abdomen pain in adults population and bring the proceedings.Materials and methods: An analysis of papers avaliable on Pubmed and Google Scholar was performed. The following key words: urachal anomalies, adults, abdomen pain, urachal remnants, urachal carcinoma were used.Results:Lately, thanks to modern precise imaging diagnostics, more valuable studies have been conducted, allowing to characterize residual ureteral remnants, which are most often asymptomatic in population of adults. However the manifestation of symptoms is mostly associated with infection of the mentioned area or a tumor transformation. There are at least two case reports which report that infection of urachal remnants could manifestate after intensive physical activity. It is worth in-depth interviewing. Studies indicate the necessity of surgical removal of persistent urachal anomalies, as they carry the risk of rapid growth and unfavorable prognosis of cancerous spread.

8 July 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JMJustyna Marcicka
Justyna Marcicka
WMWojciech Madry
Wojciech Madry
AMAleksandra Mazurkiewicz
Aleksandra Mazurkiewicz
MKMagdalena Kołodziej
Magdalena Kołodziej
JMJoanna Męczyńska
Joanna Męczyńska
WSWeronika Salasa
Weronika Salasa
In recent years, interest in probiotics in publications has been steadily increasing. This is associated with the discovery of the relationship between disruptions in the gut microbiome and dysfunction of the immune system, and consequently, the development of various diseases and allergies. The composition of the natural gut microbiota in newborns can undergo changes, and as a result, we can influence it both prenatally and postnatally. According to available research, factors influencing it include the timing and method of delivery, maternal antibiotic use during pregnancy and breastfeeding, as well as antibiotic use in newborns after birth, and the method of feeding the child. It is suspected that disturbances in the composition of gut microbiota from the earliest stages of life contribute to the development of disorders such as functional gastrointestinal disorders (diarrhea, constipation, irritable bowel syndrome), inflammatory bowel diseases, allergies, atopic dermatitis, neurodevelopmental disorders (autism spectrum disorders), and increased risk of obesity in later years of the child's life. When significant dysbiosis occurs, stimulating the growth of protective and nutritive autochthonous bacteria on the intestinal epithelium is difficult to achieve in any other way than using appropriately selected probiotic strains. However, it is important to remember to choose probiotics with a well-researched quantitative and qualitative composition, and to select them depending on the underlying disease, as well as the age and other conditions of the patient.

19 April 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
TSTomasz Seredyński
Tomasz Seredyński
WMWojciech Madry
Wojciech Madry
AMAleksandra Mazurkiewicz
Aleksandra Mazurkiewicz
MKMagdalena Kołodziej
Magdalena Kołodziej
JMJoanna Męczyńska
Joanna Męczyńska
WSWeronika Salasa
Weronika Salasa
In recent years, there has been a growing interest in the interplay between lifestyle choices, particularly non-pharmacological methods, and their profound impact on gut health. This burgeoning interest is fuelled by a growing body of research highlighting the pivotal role of the gut microbiota in maintaining overall health and well-being. Aim of the study: The aim of this review is to explore the nexus between an optimal health-related choices and gut microbiota composition, highlighting the latest research findings and insights into how dietary patterns, physical activity, psychological stress and sleep quality influence microbial diversity and functionality. Materials and methods: A comprehensive examination of scientific literature available in the PubMed and Google Scholar databases was undertaken. The search strategy incorporated keywords such as "gut”, “gut microbiota”, “exercise”, “diet”, “stress” and “circadian rhythm” to identify relevant articles. Results: The literature review findings unequivocally reveal an increased diversity in the gut microbial community and a favourable balance between commensal and pathogenic bacteria, as well as overall gut health, including integrity and functionality, attributable to adherence to a healthy lifestyle. These findings highlight the intricate interplay between lifestyle factors and colon microbial composition. Conclusions: Although initial findings are encouraging, additional investigation into the potential impact of gut microbiota on health, particularly in the long term, is indispensable. Moreover, the limitations inherent in current research methodologies, such as small sample sizes, variability in study designs, and inconsistencies in findings, underscore the need for robust, well-controlled studies to validate and expand upon existing findings. Robust studies are necessary to develop targeted interventions for optimizing gut health.

19 April 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MKMagdalena Kołodziej
Magdalena Kołodziej
MKMichał Andrzej Kozicz
Michał Andrzej Kozicz
NSNazarii Saiuk
Nazarii Saiuk
JMJustyna Marcicka
Justyna Marcicka
WMWojciech Madry
Wojciech Madry
WSWeronika Salasa
Weronika Salasa
Introduction: Bladder cancer is one of the most common cancers in the world. There are two forms of bladder cancer: non-muscle invasive bladder cancer and muscle invasive bladder cancer. A common treatment method for non- muscle invasive bladder cancer is intravesical BCG (Mycobaterium bovis) therapy after radical tumor resection. It is estimated that half of patients will have an insufficient response to BCG treatment. Patients using this type of therapy also report side effects more and more often. Aim of the study: The aim of this article is to discuss the latest discoveries in the treatment of non-muscle invasive bladder cancer when BCG therapy is insufficient. Material and Methods: The paper was created based on the PubMed and Scholar database. The literature was reviewed using the key words: „bladder cancer”; „BCG”; „treatment”; „side effects”; „novel therapies”. Results: The research shows that novel therapies are effective and safe compared to the use of BCG. In such patients, atezolizumab, metformin or intravesical magnesium sulfate infusions may be used as an alternative. An innovative solution is the use of HIVEC - heated chemotherapy administered intravesically. There are also drugs that potentiate the action of BCG, making the therapy more effective. These include: sasanlimab and rapamycin. Due to the side effects experienced by patients, the use of intravesical BCG is often replaced with intravesical infusions of chemotherapy drugs. Conclusion: The research shows that novel therapies are effective compared to the use of BCG. Unfortunately, more research is needed to standardize the treatment of non-muscle invasive bladder cancer.